Impact of CD177 on extent of and recovery from disability after ischemic stroke

Impact of CD177 on extent of and recovery from disability after ischemic stroke - CD177_stroke

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030825

Enrollment

800

Registered

2023-01-13

Start date

2022-10-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I63

Interventions

Group 1: patients with first-ever ischemic stroke This is an observational study, only patients with first-ever ischemic stroke will be included. Based on the analyses of the blood samples, this total

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: adult patients with first-ever acute (up to 48 hours after symptom onset) ischemic stroke

Exclusion criteria

Exclusion criteria: previous strokes, subacute or chronic strokes (>48 hours after symptom onset), hemorrhagic strokes, no consent

Design outcomes

Primary

Measure	Time frame
NIHSS, Barthel-Index, mRS in the acute phase (24-36 hours after hospital admission), subacute phase (72-96 hours) and chronic phase (3 months) stratified by CD177 status	—

Secondary

Measure	Time frame
Cognition (MoCA), depressive symptoms (PSD questionnaire by Nolte 2006), quality of life (SF12) stratified by CD177 status	—

Countries

Germany

Contacts

Public ContactDirk M Hermann

Universitätsklinikum Essen

dirk.hermann@uk-essen.de+492017232180

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026